Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Rapid CommunicationMinireview—Axelrod Symposium 2017

Biased Agonism in Drug Discovery—Is It Too Soon to Choose a Path?

Martin C. Michel and Steven J. Charlton
Molecular Pharmacology April 2018, 93 (4) 259-265; DOI: https://doi.org/10.1124/mol.117.110890
Martin C. Michel
Department of Pharmacology, Johannes Gutenberg University, Mainz, Germany (M.C.M.); Department of Life Sciences, University of Nottingham, Nottingham, United Kingdom (S.J.C.); and Excellerate Biosciences Ltd., MediCity, Nottingham, United Kingdom (S.J.C.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven J. Charlton
Department of Pharmacology, Johannes Gutenberg University, Mainz, Germany (M.C.M.); Department of Life Sciences, University of Nottingham, Nottingham, United Kingdom (S.J.C.); and Excellerate Biosciences Ltd., MediCity, Nottingham, United Kingdom (S.J.C.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 93 no. 4 259-265
DOI 
https://doi.org/10.1124/mol.117.110890
PubMed 
29326242

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received October 20, 2017
  • Accepted January 1, 2018
  • Published online February 20, 2018.

Article Versions

  • Earlier version (January 11, 2018 - 08:44).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Martin C. Michel and
  2. Steven J. Charlton
  1. Department of Pharmacology, Johannes Gutenberg University, Mainz, Germany (M.C.M.); Department of Life Sciences, University of Nottingham, Nottingham, United Kingdom (S.J.C.); and Excellerate Biosciences Ltd., MediCity, Nottingham, United Kingdom (S.J.C.)
  1. Address correspondence to:
    Martin C. Michel, Department of Pharmacology, Johannes Gutenberg University, Obere Zahlbacher Strasse, 67, 55131 Mainz, Germany. E-mail: marmiche{at}uni-mainz.de
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: January 2018 to February 2021

AbstractFullPdf
Jan 20183640242
Feb 201829667114
Mar 201842315162
Apr 201840165101
May 201830142113
Jun 20181253168
Jul 20181001869
Aug 20181202258
Sep 20181403176
Oct 201818649131
Nov 20181734088
Dec 20181612597
Jan 20191343491
Feb 20191406694
Mar 201947158123
Apr 201947175184
May 201937272150
Jun 20194762991
Jul 20192858064
Aug 201929446100
Sep 20192929582
Oct 20192542599
Nov 201953480144
Dec 20193765154
Jan 20201872973
Feb 20202765378
Mar 20203689893
Apr 202034993159
May 202024953141
Jun 20201366473
Jul 20201260578
Aug 20201361658
Sep 202018805114
Oct 202025795104
Nov 20201488396
Dec 20201844257
Jan 20211532880
Feb 2021626557

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 93 (4)
Molecular Pharmacology
Vol. 93, Issue 4
1 Apr 2018
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Biased Agonism in Drug Discovery—Is It Too Soon to Choose a Path?
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Rapid CommunicationMinireview—Axelrod Symposium 2017

Biased Agonism in Drug Discovery

Martin C. Michel and Steven J. Charlton
Molecular Pharmacology April 1, 2018, 93 (4) 259-265; DOI: https://doi.org/10.1124/mol.117.110890

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Rapid CommunicationMinireview—Axelrod Symposium 2017

Biased Agonism in Drug Discovery

Martin C. Michel and Steven J. Charlton
Molecular Pharmacology April 1, 2018, 93 (4) 259-265; DOI: https://doi.org/10.1124/mol.117.110890
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • The Promise of Biased Agonism
    • The Unfulfilled Promise of Biased Agonism
    • The Challenge for Drug Discovery
    • Conclusions
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Caveolins and Stress
Show more Minireview—Axelrod Symposium 2017

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics